Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: A Focus on the Role of the Pharmacist
Jessica Farrell,1 Lawrence Ho2 1Albany College of Pharmacy and Health Sciences and Albany Medical Center Division of Rheumatology, Albany, NY, USA; 2Center for Interstitial Lung Disease, University of Washington, Seattle, WA, USACorrespondence: Jessica Farrell, Albany College of Pharmacy and Health...
Saved in:
Main Authors: | Farrell J (Author), Ho L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic and Therapeutic Conundrums in Systemic Sclerosis Interstitial Lung Disease
by: Ramaswamy Subramanian, et al.
Published: (2022) -
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
by: Elisabetta Zanatta, et al.
Published: (2022) -
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review
by: Martina Orlandi, et al.
Published: (2022) -
Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis
by: C. Giacomelli, et al.
Published: (2011) -
The Association between MUC5B Rs35705950 and Risks of Idiopathic Interstitial Pneumonia, Systemic Sclerosis Interstitial Lung Disease, and Familial Interstitial Pneumonia: A Meta-Analysis
by: Huai-qing LUO, et al.
Published: (2020)